A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation

Moscow State budget healthcare /ID# 212875, Moscow

Moscow Regional Research and Clinical Institute n.a. Vladimirskiy (MONIKI) /ID# 215830, Moscow

Regional Clinical Hospital of Vologda /ID# 212471, Vologda

Komi Republican Oncology Dispensary /ID# 212370, Syktyvkar

Russian Research Institute of Hematology and Transfusiology of the FMBA /ID# 212372, Saint Petersburg

Academician I.P. Pavlov First St. Petersburg State Medical University /ID# 212368, Saint Petersburg

Almazov National Medical Research Centre /ID# 212365, Saint Petersburg

Policlinic #2 /ID# 214778, Oryol

Oncology Dispensary #2 /ID# 215831, Sochi

Regional Children's Clinical Hospital of Volgograd /ID# 212366, Volgograd

City Clinical Hospital # 5 /ID# 212369, Vladimir

Kirov Regional Clinical Hospital /ID# 217579, Kirov

Clinical Medico-Sanitary Unit #1 /ID# 212364, Perm

Sverdlovsk Regional Clinical Hospital #1 /ID# 214777, Yekaterinburg

Central City Hospital #7 /ID# 212373, Yekaterinburg

Krai Clinical Hospital /ID# 224952, Barnaul

GBUZ Regional Cancer center /ID# 216871, Irkutsk

Republican Hospital #1 - National Center of Medicine of Sakha (Yakutia) /ID# 212371, Yakutsk

Krai Clinical Hospital #1 /ID# 212367, Khabarovsk

Sakhalin Regional Clinical Hospital /ID# 222503, Yuzhno-Sakhalinsk